Related Experiment Videos
Catalytic antibodies and their applications
Carl Veith Hanson1, Yasuhiro Nishiyama, Sudhir Paul
1Viral and Rickettsial Disease Laboratory, California Department of Health Services, Richmond, 94804, USA. chanson1@dhs.ca.gov
Current Opinion in Biotechnology
|October 26, 2005
Summary
Catalytic antibodies (CAbs) are naturally occurring or engineered proteins that accelerate chemical reactions. These versatile molecules show significant potential in medicine, from drug activation to treating neurodegenerative diseases like Alzheimer's.
Area of Science:
- Immunology
- Biochemistry
- Medicinal Chemistry
Background:
- Catalytic antibodies (CAbs) are found in healthy individuals and are more prevalent in autoimmune diseases.
- They can be artificially generated through immunization or engineering.
- CAbs function through various catalytic mechanisms, including nucleophilic catalysis and transition state stabilization.
Purpose of the Study:
- To review the mechanisms of action for catalytic antibodies.
- To highlight recent and potential clinical applications of CAbs.
- To discuss the future prospects of artificial CAbs in various fields.
Main Methods:
- Review of existing literature on catalytic antibodies.
- Analysis of reported mechanisms of CAb catalysis.
- Compilation of current and emerging CAb applications.
Main Results:
- CAbs utilize diverse mechanisms like nucleophilic catalysis and transition state stabilization.
- Significant clinical applications include cocaine and nicotine detoxification, prodrug activation, UV protection, HIV inhibition, and Alzheimer's disease treatment.
- Artificial CAbs demonstrate broad utility.
Conclusions:
- Catalytic antibodies possess diverse catalytic mechanisms.
- CAbs have demonstrated significant clinical relevance in various therapeutic areas.
- Artificial CAbs are poised for expanded use in research, medicine, diagnostics, and manufacturing.